Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study.

CONCLUSIONS: These data suggest that in Paris area, a 2-year, 3-year and 4-year screening interval was considered safe for type 1 DM, type 2 DM and for low-risk patients with type 2 DM, respectively, without DR at the first examination. While these data might be used to support the consideration of extending screening intervals, a randomised clinical trial would be suitable to confirm the safety for patients with DM.
PMID: 32522790 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - June 9, 2020 Category: Opthalmology Authors: Chamard C, Daien V, Erginay A, Gautier JF, Villain M, Tadayoni R, Carriere I, Massin P Tags: Br J Ophthalmol Source Type: research